BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17021367)

  • 1. Fatty acid metabolism, the central nervous system, and feeding.
    Ronnett GV; Kleman AM; Kim EK; Landree LE; Tu Y
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():201S-207S. PubMed ID: 17021367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid metabolism as a target for obesity treatment.
    Ronnett GV; Kim EK; Landree LE; Tu Y
    Physiol Behav; 2005 May; 85(1):25-35. PubMed ID: 15878185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
    Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The connections between C75 and obesity drug-target pathways.
    Kuhajda FP; Landree LE; Ronnett GV
    Trends Pharmacol Sci; 2005 Nov; 26(11):541-4. PubMed ID: 16169094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
    Tu Y; Thupari JN; Kim EK; Pinn ML; Moran TH; Ronnett GV; Kuhajda FP
    Endocrinology; 2005 Jan; 146(1):486-93. PubMed ID: 15498887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
    Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
    Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
    Thupari JN; Landree LE; Ronnett GV; Kuhajda FP
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9498-502. PubMed ID: 12060712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
    Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
    Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
    Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
    Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity.
    Kuhajda FP; Ronnett GV
    Curr Opin Investig Drugs; 2007 Apr; 8(4):312-7. PubMed ID: 17458181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight.
    Aja S; Landree LE; Kleman AM; Medghalchi SM; Vadlamudi A; McFadden JM; Aplasca A; Hyun J; Plummer E; Daniels K; Kemm M; Townsend CA; Thupari JN; Kuhajda FP; Moran TH; Ronnett GV
    Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R352-61. PubMed ID: 18056987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure.
    Lane MD; Hu Z; Cha SH; Dai Y; Wolfgang M; Sidhaye A
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1063-7. PubMed ID: 16246046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of fatty acid synthase for lung cancer treatment.
    Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
    Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fatty acid synthase is a therapeutic target in mesothelioma.
    Gabrielson EW; Pinn ML; Testa JR; Kuhajda FP
    Clin Cancer Res; 2001 Jan; 7(1):153-7. PubMed ID: 11205903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipids in the control of food intake.
    Fantino M
    Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):138-44. PubMed ID: 21252653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase.
    Tian WX; Li LC; Wu XD; Chen CC
    Life Sci; 2004 Mar; 74(19):2389-99. PubMed ID: 14998716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of food intake by inhibitors of fatty acid synthase.
    Bouchard C
    N Engl J Med; 2000 Dec; 343(25):1888-9. PubMed ID: 11117983
    [No Abstract]   [Full Text] [Related]  

  • 20. C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.
    Mera P; Bentebibel A; López-Viñas E; Cordente AG; Gurunathan C; Sebastián D; Vázquez I; Herrero L; Ariza X; Gómez-Puertas P; Asins G; Serra D; García J; Hegardt FG
    Biochem Pharmacol; 2009 Mar; 77(6):1084-95. PubMed ID: 19094968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.